Healthy Japanese
Conditions
Interventions
Consumption of test food 1 for 4 weeks
Consumption of test food 2 for 4 weeks
Consumption of placebo for 4 weeks
Sponsors
Asahi Group Foods, Ltd.
Metagen, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. At informed consent, male/female subjects aged more than or equal to 20, and less than 65 years old 2. Subjects who defecate at least 3 times per week 3. Subjects who can show their understanding of the study procedure and agreement with participating in the study by written informed consent prior to the study
Exclusion criteria
Exclusion criteria: 1. Subjects who regularly consume foods for specified health uses, foods with function claims, supplement and/or health foods, which would affect the trial results for more than 3 times a week, and who are unable to discontinue consumption from the day of the preliminary test 2. Subjects who have taken medications that would affect the study (e.g., bowel preparation, laxatives, etc.) for one month prior to the start of consumption of the test food, and who are unable to limit the use of such medications during the study period 3. Subjects who have taken antibiotics affecting the study for more than 2 months prior to the intervention period, and who cannot limit their use during the study period 4. Subjects who are currently undergoing other clinical trials with any kind of medicine/food, or who have participated in such trials within a month before this trial, or who will participate in such trials after giving informed consent to participate in this trial 5. Subjects with irregular dietary habits 6. Subjects who are expected to undergo major changes in their living environment, such as home and/or work, during this trial 7. Subjects whose roomer is planning to join this trial 8. Subjects who are smoker 9. Subjects who take excessive alcohol, defined as "drinkers whose average weekly alcohol intake exceeds 60 grams/day" 10. Subjects who had undergone appendectomy 11. Subjects who have received the surgery which would affect the trial result within half a year before obtaining a consent 12. Subjects who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases 13. Pregnant, possibly pregnant, or lactating women 14. Subjects who are allergic to medicines and/or foods 15. Others who have been determined ineligible by the study representative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal short-chain fatty acids | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fecal microbiota 2. The status of defecation | — |
Countries
Japan
Contacts
Public ContactMisaki Hatanaka
Asahi Group Foods, Ltd. Technology Research&Development Department 1
Outcome results
None listed